Videos

A uveitis specialist discusses impressions and key take away points from patient case.

Impressions and take away points from Patient Case #1

Dr. Eduardo Uchiyama, MD reviews the case of a 65-year-old female with uveitis. 

Patient case #1: 65-year-old patient with uveitis

Articles

An end-of-week review of retina news and stories from June 18 to June 24.

This week in retina: June 18-June 24

Sheryl brings a wealth of editorial experience to MJH Life Sciences’ Eye Care Network, having engaged with the readers and the greater ophthalmic community of 

for more than 20 years. As Group Editorial Director, Sheryl’s purview extends across the print and digital network of 

Ophthalmology Times, Ophthalmology Times Europe, Modern Retina 

 Prior to ophthalmology, Sheryl previously covered the fields of audiology and confectionery science/technology/manufacturing.

Sheryl is also passionate about the mission, vision and values of Ophthalmic World Leaders (OWL) and recently completed her term on its Board of Directors. She continues to volunteer as Editor-in-Chief of the organization’s 

Magazine. In 2013, she was honored with the group’s inaugural Rising Star Award.

In addition, she has served as a judge for 

 Health Care Heroes Awards program as well as the Jesse H. Neal National Business Journalism Awards.

Steven Yeh, MD, provides a brief overview of available therapies for noninfectious uveitis and uveitis macular edema.

Expanding the therapeutic arsenal for noninfectious uveitis, uveitic macular edema

David Boyer, MD, discusses the Phase 3 investigation for OPT-302 combination therapy for wet AMD.

Phase 3 investigation of OPT-302 combination therapy assess superiority in mean BCVA over anti-VEGF-A monotherapy

The U.S. Centers for Medicare and Medicaid Services code is effective July 1 and will enhance access to Xipere, the only therapy available in the United States for suprachoroidal use in the treatment of macular edema associated with uveitis.

Permanent J-code granted for triamcinolone acetonide injectable suspension from Bausch + Lomb

A study by Orbis International found that children with myopia experienced significantly higher levels of depression and anxiety than their peers without vision impairment.

Pediatric vision impairment associated with increased risk of depression, anxiety

A team led by researchers from the University of Geneva has identified a molecular mechanism that causes degeneration of the eye’s photoreceptors, which can lead to blindness.

Molecular mechanism discovered to cause photoreceptor degeneration in retinitis pigmentosa

A retina specialist discusses impressions and key take away points from patient case.

Impressions and take away points from Patient Case #2

Eduardo Uchiyama MD reviews the case of a 55-year-old male with non-infectious uveitis.

Molecular mechanism discovered to cause photoreceptor degeneration in retinitis pigmentosa

Impressions and take away points from Patient Case #2

Patient case #2: 52-year-old patient with recurrent uveitis